Who Owns Medtronic?
Medtronic is the flagship brand of Medtronic plc (NYSE: MDT), the world's largest medical device company, legally domiciled in Galway, Ireland, and operationally headquartered in Minneapolis, Minnesota. Founded in 1949, the brand covers pacemakers, heart valves, spinal implants, neuromodulation devices, and surgical products generating $36.4 billion in FY2026 revenue.
GlobalOfficial Website
Who Owns Medtronic?
- Parent Company: Medtronic plc
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: MDT
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Medtronic | Medtronic plc | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
Medtronic on AmazonAdvertisement
History of Medtronic
- Founded: 1949
- Founders: Earl Bakken, Palmer Hermundslie
The Medtronic brand began in 1949 in a Minneapolis garage, where Earl Bakken and Palmer Hermundslie ran a medical equipment repair shop. The brand's defining product arrived in 1957, when Bakken built the first battery-powered wearable pacemaker at the request of heart surgeon C. Walton Lillehei. Implantable pacemakers followed in 1960, and cardiac pacing established the brand's identity for decades.
Through the 1960s and 1970s, Medtronic became synonymous with the pacemaker itself, expanding into heart valves and, in the 1980s, implantable defibrillators. The brand went public in the 1970s and used its cardiology cash flows to move into spinal devices, neurological stimulation, and drug delivery pumps.
The brand absorbed several large acquisitions between 1999 and 2015. Sofamor Danek (1999, about $3.7 billion) brought spinal implants, MiniMed (2001, roughly $3.7 billion) added insulin pumps, Kyphon (2007, about $3.9 billion) expanded spine, and Covidien (2015, approximately $42.9 billion) contributed the surgical instruments and patient monitoring lines that now form the Medical Surgical segment. The Covidien deal also moved the brand's legal home to Ireland.
Recent product history centers on leadless cardiac devices and robotics. The Micra pacemaker, commercialized in 2015 and FDA approved in 2016, became the first widely adopted leadless pacing system. The Hugo robotic-assisted surgery system reached the U.S. market with FDA clearance in December 2025. In October 2026, the MiniMed diabetes brand separated into an independent public company, leaving Medtronic as a pure hospital-facing device brand.
Advertisement
About Medtronic plc
What does Medtronic own?
Medtronic owns the Medtronic device portfolio across cardiovascular, neuroscience, and surgical categories, including named product lines such as Micra, Hugo, Evolut, Mazor, StealthStation, and Valleylab. It no longer owns MiniMed, which became a fully independent public company in October 2026.
Is Medtronic publicly traded?
Yes. Medtronic plc trades on the New York Stock Exchange under ticker MDT and is a component of the S&P 500. It is an Irish-domiciled company that reports as a U.S. domestic issuer.
Who founded Medtronic?
Earl Bakken and his brother-in-law Palmer Hermundslie founded the company in a Minneapolis garage in 1949 as a medical equipment repair business. Bakken invented the first battery-powered wearable pacemaker in 1957.
Where is Medtronic headquartered?
Medtronic is legally domiciled in Galway, Ireland, following the 2015 Covidien acquisition. Its operational headquarters and executive leadership are in Minneapolis, Minnesota.
Advertisement
How many brands does Medtronic own?
Medtronic operates primarily as a master-brand company. Products carry Medtronic branding with trade names like Micra, Hugo, Evolut, and Symplicity. It has fewer than a dozen standalone consumer-facing names.
Who owns Medtronic?
The company is owned by public shareholders with no controlling interest. The largest holders are index investors including Vanguard, BlackRock, and State Street. Geoff Martha serves as Chairman and CEO.
Has Medtronic made major acquisitions recently?
The largest deal in company history was the $42.9 billion Covidien acquisition completed in 2015. More recently it acquired Mazor Robotics (2018, about $1.64 billion) and Affera (2022, about $1 billion). Its biggest recent transaction was a divestiture: the October 2026 separation of MiniMed.
What is Medtronic's revenue?
Medtronic reported FY2026 revenue of $36.4 billion, up 8.4%, its fastest annual growth in ten years. In Q1 FY2027 it posted $9.8 billion in revenue, up 13.7%, and raised full-year guidance.
Advertisement
- Founded: 1949
- Headquarters: Galway, Ireland; operational headquarters Minneapolis, Minnesota, USA
- Company Type: Publicly Traded
- Stock: NYSE: MDT
- Revenue: $36.4 billion (FY2026, ended April 24, 2026)
- Employees: Approximately 95,000
Where Is Medtronic Made / Based?
- Headquarters: Minneapolis, Minnesota, USA
- Manufacturing / Operations: United States, Ireland, Puerto Rico, Mexico, Costa Rica, China, Singapore
Medtronic Categories & Tags
Medtronic Recalls & Controversies
The brand carries a documented recall history typical of a company that has sold implantable devices for seven decades. The 2007 Sprint Fidelis defibrillator lead withdrawal produced litigation settled for approximately $268 million. The Infuse bone graft controversy led to a 2012 Senate Finance Committee investigation and settlements exceeding $160 million.
In June 2021, Medtronic discontinued the HeartWare ventricular assist device following FDA Class I recalls. The MiniMed insulin pump line, before its separation, carried Class I recalls in 2019 and 2020 including a cybersecurity vulnerability. An FDA warning letter to the Northridge diabetes facility in 2021 addressed quality system deficiencies. All matters noted have documented resolutions or disclosed status.
Brands Owned by Medtronic plc
Healthcare PharmaceuticalsHugo
Owned by Medtronic plc
Medtronic's Hugo robotic-assisted surgery system for soft-tissue procedures, FDA cleared for urologic surgery in December 2025.
surgical-roboticsmedtechmedical-devices
Healthcare PharmaceuticalsMicra
Owned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
medical-devicespacemakerscardiology
Advertisement
Medtronic Ownership: Pros & Cons
Advantages
- +World's largest pure-play medical device brand at $36.4 billion FY2026 revenue
- +Recurring implant and consumable revenue provides durable cash flows
- +$2.9 billion annual R&D supports a deep device pipeline
- +More than four decades of annual dividend increases
- +Strong positions in cardiac rhythm, structural heart, and surgical robotics
Considerations
- -Documented recall history across cardiac and diabetes product lines
- -Post-MiniMed portfolio loses roughly $3 billion in annual revenue
- -Spine and neuromodulation segments grow more slowly than cardiovascular
- -Surgical robotics entry trails Intuitive Surgical's installed base by decades
- -Irish domicile adds tax complexity and periodic political scrutiny
Frequently Asked Questions About Medtronic
Advertisement
Sources & Further Reading
Competitors to Medtronic
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Medtronic | USA | 2015 | Mass market | Global | All Genders | |
| Boston Scientific | USA | 1979 | Mass market | Global | All Genders | |
| Stryker | USA | 1941 | Market leader | Global | All Genders | |
| Medtronic | USA | 2021 | Mass market | Global | All Genders | |
| Becton Dickinson | USA | 1897 | Mass market | Global | All Genders | |
| Ge Healthcare | USA | 2023 | Mass market | Global | All Genders |
Learn More About Competitors
Healthcare PharmaceuticalsMicra
Owned by Medtronic plc
Medtronic's Micra leadless pacemaker family, the world's smallest pacemakers, implanted directly in the heart and used in more than 300,000 patients.
medical-devicespacemakerscardiology
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Healthcare PharmaceuticalsStryker
Owned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
medical-devicesorthopaedicssurgical-equipment
Healthcare PharmaceuticalsHugo
Owned by Medtronic plc
Medtronic's Hugo robotic-assisted surgery system for soft-tissue procedures, FDA cleared for urologic surgery in December 2025.
surgical-roboticsmedtechmedical-devices
Healthcare PharmaceuticalsBD
Owned by Becton, Dickinson and Company
Master brand of Becton, Dickinson and Company, the medical technology company behind Vacutainer, Pyxis, Alaris, and Bard product lines.
medical-devicesmedtechhospital-supplies
Healthcare PharmaceuticalsGE Imaging
Owned by GE HealthCare Technologies Inc.
Medical imaging equipment brand of GE HealthCare, covering MRI, CT, X-ray, and molecular imaging systems used in hospitals and diagnostic centers worldwide.
medical-devicesimagingmri
Competitive Analysis
Market Positioning: Medtronic competes with 6 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Advertisement
Independent Alternatives to Medtronic
Looking for brands with different ownership structures? These similar brands are not owned by Medtronic plc, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsBand-Aid
Owned by Kenvue
American adhesive bandage brand invented in 1921, owned by Kenvue Inc. Band-Aid is the leading adhesive bandage brand in the United States and is sold in more than 100 countries.
wound-careadhesive-bandagefirst-aid
Privately Owned
Band-Aid is privately owned, unlike Medtronic which is under a publicly traded parent company.
Healthcare PharmaceuticalsBoston Scientific
Owned by Boston Scientific Corporation
Corporate brand of Boston Scientific Corporation, the Marlborough, Massachusetts medical device maker behind WATCHMAN and FARAPULSE.
medical-devicescardiologymedtech
Publicly Traded
Boston Scientific operates independently without a large parent corporation.
Healthcare PharmaceuticalsStryker
Owned by Stryker Corporation
Flagship medical technology brand of Stryker Corporation, founded in 1941 and a global leader in orthopaedic implants and surgical equipment.
medical-devicesorthopaedicssurgical-equipment
Publicly Traded
Stryker operates independently without a large parent corporation.
Healthcare PharmaceuticalsTylenol
Owned by Kenvue
American brand of pain relief medication and analgesic drugs, flagship product of Kenvue Inc., the consumer health company spun off from Johnson and Johnson in 2023. Kimberly-Clark is acquiring Kenvue in a deal closed on November 2, 2026.
pain-reliefmedicationpharmaceutical
Privately Owned
Tylenol is privately owned, unlike Medtronic which is under a publicly traded parent company.
Healthcare PharmaceuticalsWalgreens
Owned by Walgreens Boots Alliance
Walgreens is the largest U.S. pharmacy retail brand, operating roughly 8,000 stores. It went private in August 2025 under Sycamore Partners as a standalone company.
pharmacydrugstoreretail-pharmacy
Privately Owned
Walgreens is privately owned, unlike Medtronic which is under a publicly traded parent company.
Healthcare PharmaceuticalsZocdoc
Owned by Zocdoc, Inc.
Online healthcare marketplace where patients find in-network doctors and book appointments instantly, a private New York company valued at $1.8 billion.
healthcareappointment-bookingdigital-health
Privately Owned
Zocdoc is privately owned, unlike Medtronic which is under a publicly traded parent company.
Medtronic plc Stock Information
Advertisement
Jobs at Medtronic plc
Latest News About Medtronic
Advertisement
Related Articles About Medtronic
View more articles
Brand Comparisons
Pfizer vs Johnson & Johnson: Pharma Brand Portfolios Compared
Pfizer and Johnson & Johnson are two of the most recognizable names in healthcare. But their brand portfolios look nothing alike. Here is a complete breakdown of what each company owns, how they got there, and what sets them apart.
Who Brands StaffMar 16, 2026
PharmaceuticalPfizerJohnson And Johnson
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS spent $69 billion to buy Aetna. Walgreens acquired Boots for $15 billion. Amazon paid $1 billion for PillPack. Here are 15 pharmacy brands, who owns them, and how a once-diverse industry collapsed into two dominant players.
Who Brands StaffFeb 26, 2026
Pharmacy BrandsBrand OwnershipCvs
Brand Ownership
Who Owns Your Vitamins? The Hidden Corporate Parents Behind Supplement Brands
The supplement industry is worth $60+ billion but most brands are owned by pharma giants and food conglomerates. Here is who owns every major vitamin and supplement brand.
Who Brands StaffFeb 5, 2026
VitaminsSupplementsBrand Ownership
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth